logo
#

Latest news with #MAT

‘Out of syllabus' questions: HC asks MPSC to share expert view
‘Out of syllabus' questions: HC asks MPSC to share expert view

Time of India

time7 days ago

  • Business
  • Time of India

‘Out of syllabus' questions: HC asks MPSC to share expert view

Mumbai: The Bombay High Court has directed the Maharashtra Public Service Commission (MPSC) to submit the expert opinion obtained by it regarding allegedly outside the syllabus questions asked in an April 2018 departmental examination. "In our view, it would be necessary to consider the opinion expressed by the expert relied upon by the MPSC. Prima facie, we do not find any justification for depriving the candidates of the opinion expressed by the expert," said Justices A S Chandurkar and Milind Sathaye in Tuesday's order. The HC order came on the MPSC's petitinon challenging the Maharashtra Administrative Tribunal's Nov 2022 judgment. The exams for the post of assistant accounts officer were held in April 2018, and results were declared in Oct 2019. Candidates complained that the questions in a paper were beyond the syllabus, affecting their performance. MPSC claimed the questions were within the syllabus. Further, according to the opinion of an expert, they were valid. MAT held that the three questions were beyond the prescribed syllabus. While declining the candidates' prayer for full marks for these questions, it directed MPSC to allot marks in a manner indicated in its judgment. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo MPSC moved HC stating that MAT could not have disregarded the expert's opinion. The candidates also challenged a part of the judgment which denied further relief despite MAT recording a finding that the questions were out of syllabus. The expert's opinion was not revealed to them before MAT. The HC judges noted that MPSC relied on an expert's opinion to substantiate its stand and furnished it to MAT in a sealed envelope. MPSC's reply before MAT stated that, according to the expert's opinion, the questions are related to the Bombay Civil Services Rules and the day-to-day important working of the govt and are in accordance with the syllabus. The judges said the issue of whether the questions "were out of syllabus or not goes to the root of the matter" and "much would therefore depend upon the opinion expressed by the expert." "The tribunal has considered the opinion but has thereafter disregarded the same," they added. Hence, before proceeding with the hearing, the judges deemed it appropriate to direct MPSC to place on record the opinion. It would enable the court to consider whether the tribunal was justified in concluding that the questions were out of syllabus, the judge said. "Similarly, the candidates would also have an opportunity to contest the opinion of the expert in support of their stand that the said questions were indeed out of syllabus," they concluded.

Top CBSE students can now get full scholarship to Hong Kong University. Know how
Top CBSE students can now get full scholarship to Hong Kong University. Know how

India Today

time24-05-2025

  • Business
  • India Today

Top CBSE students can now get full scholarship to Hong Kong University. Know how

The University of Hong Kong is offering full-ride scholarships to top-performing CBSE students for various undergraduate programmes, focusing on innovation, technology, and interdisciplinary studies. Know the eligibility and application details here. India Today Education Desk HKU offers full scholarships to top CBSE students for select undergraduate programmes Courses include fields like Artificial Intelligence, Business Analytics, and Biomedical Engineering Applicants should refer to HKU's official website for detailed eligibility and application procedures The University of Hong Kong (HKU), ranked 17th globally in the QS World University Rankings 2025, has announced full-ride scholarships for top-performing students from the Central Board of Secondary Education (CBSE). This initiative aims to support outstanding CBSE students seeking undergraduate admission at HKU, particularly in fields aligned with innovation, technology, and interdisciplinary studies. The university's decision comes in light of CBSE's emphasis on competency-based education under the New Education Policy (NEP) 2020, which has enhanced student performance across disciplines, including STEM and the humanities. COURSES COVERED UNDER THE SCHOLARSHIP HKU is offering a range of cutting-edge courses eligible under this scholarship scheme, such as: BA in Humanities and Digital Technologies (HDT) BBA (Business Analytics) BSc in Marketing Analytics and Technology (MAT) BSc in Quantitative Finance (QFin) BA in Global Creative Industries (GCIN) BBA BEng - Global Engineering and Business Programme (GEBP) BEng Elite Programme BEng X+ MScEng - Master of Science in Engineering in Artificial Intelligence in Engineering (AIE) BSocSc (Major in Computational Social Science) BASc in Applied Artificial Intelligence (AppliedAI) BASc in Financial Technology (FinTech) BSc in Actuarial Science (ActuarSc) Bachelor of Statistics (BStat): (1) Decision Analytics, (2) Risk Management, and (3) Statistics BEng in Computer Science (CompSc) BEng in Artificial Intelligence and Data Science (AI&DataSc) BSc in Innovation and Technology BEng in Biomedical Engineering (BME) In addition to providing a strong foundation in core academic areas, the university offers access to over 420 global exchange partnerships in 49 countries and regions. Students will also benefit from dual degree and collaborative programmes with prestigious institutions including the University of Cambridge, University of British Columbia, and Sciences Po. HOW TO APPLY CBSE students aiming for these scholarships should apply through HKU's International/Non-JUPAS Admissions Scheme. Applicants need to submit their academic records, a personal statement, and any other required documents. It's advisable to check the official HKU admissions website for detailed application procedures and deadlines ELIGIBILITY CRITERIA While specific eligibility criteria for CBSE students haven't been detailed, HKU generally considers academic excellence in national examinations. For Indian board exams, a minimum percentage of around 90% is often expected for competitive programmes. Applicants should also meet English language requirements and any programme-specific prerequisites. For detailed information on eligibility, application process, and course offerings, students are advised to visit the official University of Hong Kong website: The University of Hong Kong (HKU), ranked 17th globally in the QS World University Rankings 2025, has announced full-ride scholarships for top-performing students from the Central Board of Secondary Education (CBSE). This initiative aims to support outstanding CBSE students seeking undergraduate admission at HKU, particularly in fields aligned with innovation, technology, and interdisciplinary studies. The university's decision comes in light of CBSE's emphasis on competency-based education under the New Education Policy (NEP) 2020, which has enhanced student performance across disciplines, including STEM and the humanities. COURSES COVERED UNDER THE SCHOLARSHIP HKU is offering a range of cutting-edge courses eligible under this scholarship scheme, such as: BA in Humanities and Digital Technologies (HDT) BBA (Business Analytics) BSc in Marketing Analytics and Technology (MAT) BSc in Quantitative Finance (QFin) BA in Global Creative Industries (GCIN) BBA BEng - Global Engineering and Business Programme (GEBP) BEng Elite Programme BEng X+ MScEng - Master of Science in Engineering in Artificial Intelligence in Engineering (AIE) BSocSc (Major in Computational Social Science) BASc in Applied Artificial Intelligence (AppliedAI) BASc in Financial Technology (FinTech) BSc in Actuarial Science (ActuarSc) Bachelor of Statistics (BStat): (1) Decision Analytics, (2) Risk Management, and (3) Statistics BEng in Computer Science (CompSc) BEng in Artificial Intelligence and Data Science (AI&DataSc) BSc in Innovation and Technology BEng in Biomedical Engineering (BME) In addition to providing a strong foundation in core academic areas, the university offers access to over 420 global exchange partnerships in 49 countries and regions. Students will also benefit from dual degree and collaborative programmes with prestigious institutions including the University of Cambridge, University of British Columbia, and Sciences Po. HOW TO APPLY CBSE students aiming for these scholarships should apply through HKU's International/Non-JUPAS Admissions Scheme. Applicants need to submit their academic records, a personal statement, and any other required documents. It's advisable to check the official HKU admissions website for detailed application procedures and deadlines ELIGIBILITY CRITERIA While specific eligibility criteria for CBSE students haven't been detailed, HKU generally considers academic excellence in national examinations. For Indian board exams, a minimum percentage of around 90% is often expected for competitive programmes. Applicants should also meet English language requirements and any programme-specific prerequisites. For detailed information on eligibility, application process, and course offerings, students are advised to visit the official University of Hong Kong website: Join our WhatsApp Channel

GATC Health Paper Quantifies AI-Driven Capital Efficiencies and Advances Human-Centered Drug Discovery
GATC Health Paper Quantifies AI-Driven Capital Efficiencies and Advances Human-Centered Drug Discovery

Yahoo

time22-05-2025

  • Business
  • Yahoo

GATC Health Paper Quantifies AI-Driven Capital Efficiencies and Advances Human-Centered Drug Discovery

IRVINE, Calif., May 22, 2025 /PRNewswire/ -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, has published a new paper, AI in Drug Development: Advancing Capital Efficiency, Reducing Animal Testing, and Driving Precision Medicine. The paper details how advancements such as GATC's Multiomics Advanced Technology™ (MAT) platform are reshaping pharmaceutical development by improving speed, cost, and accuracy while reducing reliance on animal testing through human-relevant AI models. Ultimately, these technologies provide practical solutions to the industry's key challenges and promise to deliver better, safer treatments—faster—to patients. Highlights include: Validated, Highly Accurate Predictions: GATC Health's MAT was validated by University of California, Irvine, with predictions of sensitivity at 86% and specificity at 91%. Digital Twin Models: Models of human biological systems can test thousands of drug candidates in silico—achieving results 1,000x faster than conventional methods and at dramatically lower cost. Reduction in Animal Testing: The platform simulates human biology, enabling accurate predictions without animal studies and supporting regulatory shifts like the FDA Modernization Act. AI-driven methods could replace animal testing for up to 38.4 million animals annually. Public Health Impact: Accelerated drug development means faster access to new therapeutics, with the potential to save millions of years of human life. "This paper underscores our commitment to scientific and ethical progress in drug discovery," said Jayson Uffens, Chief Technology Officer at GATC Health. "By improving capital efficiency and reducing animal testing, we aim to advance both innovation and responsibility in the industry." Transforming Drug Development EconomicsTraditional drug development can cost up to $2.4 billion and take 12 years per drug. GATC's MAT platform streamlines discovery and preclinical phases, enabling companies to avoid costly investments in unlikely candidates and reinvest savings into further research. As noted in the paper, AI-driven preclinical assessments can cut animal use, increase human relevance, and reduce expenses by up to 90%. This streamlined process can shorten time to Investigational New Drug (IND) filing from over a decade to under two years. Advancing Ethical, Cost-Effective SolutionsConventional animal models often fail to predict human outcomes and raise ethical issues. GATC's AI-driven approach reduces animal use by up to 70% per drug candidate, aligning with global moves toward non-animal testing. Virtual toxicology datasets and digital twins replace animal models with more accurate and humane alternatives. Aligning with Regulatory TrendsThe paper details how AI technologies support evolving regulatory requirements, enabling faster, more precise, and ethically responsible drug development. GATC Health invites industry stakeholders to review the full paper and participate in the ongoing dialogue about the future of drug discovery. Visit GATC Health's Resources page to download the full paper. About GATC HealthGATC Health Corp. is a technology company transforming drug discovery and development through its AI-driven platform and approach. The company's validated and proprietary Multiomics Advanced Technology™ (MAT) simulates human biochemistry's billions of interactions to rapidly create novel therapeutics, identify and confirm targets, accelerate development, and derisk drug pipelines by predicting efficacy, safety, and off-target more information, visit View original content to download multimedia: SOURCE GATC Health Corp

Gulyás: Peace will be beneficial if Europe finds common ground with the US
Gulyás: Peace will be beneficial if Europe finds common ground with the US

Budapest Times

time19-05-2025

  • Politics
  • Budapest Times

Gulyás: Peace will be beneficial if Europe finds common ground with the US

During a meeting of the Hungarian Atlantic Council (MAT) late on Thursday, Gergely Gulyás, Head of the Prime Minister's Office, said peace will be beneficial, especially if Europe, similarly to Hungary, finds common ground with the United States. Receiving the body's Antall József Prize for supporting the Transatlantic concept and aiding the council's work, Gulyás told the body's general assembly that the change of government in the US had been a 'relief' for Hungary as the previous Democrat administration had been 'expressly unfriendly'. Gulyás said 'the US does not want to protect Europe' and expects the bloc to develop its defense capabilities, which have been neglected for decades'. Meanwhile, referring to József Antall, Hungary's first prime minister after the fall of communism, Gulyás said he worked at a time when 'respect was the ruling tone of public life … that has ceased, it is no more'. 'That is a serious hit to democracy,' he said. Lauding Gulyás, Zsolt Németh, the head of parliament's foreign policy committee and the MAT vice-president, said the minister had a 'nationalist, Christian, conservative and protestant set of values' and was 'an operative problem-solver' who played a role in 'protecting the victims of the events of 2006, creating the Fundamental Law, or fostering Hungary's crucial relations with German-speaking states.'

Data shows medication-assisted treatment works for opioid use disorder—so why aren't more people getting it?
Data shows medication-assisted treatment works for opioid use disorder—so why aren't more people getting it?

Yahoo

time12-05-2025

  • Health
  • Yahoo

Data shows medication-assisted treatment works for opioid use disorder—so why aren't more people getting it?

Opioid use disorder (OUD) is a treatable but potentially life-threatening condition. Yet millions of people still lack access to the most effective treatment options. According to recently released data from the Centers for Disease Control and Prevention (CDC), medications for OUD, especially buprenorphine and methadone, can significantly reduce the risk of overdose and improve long-term health outcomes. Despite this, medication-assisted treatment (MAT) remains widely underused. In 2022, an estimated 9.4 million U.S. adults needed treatment for OUD, but only one in four (25.1%) received evidence-based MAT, according to the CDC. Nearly half (42.7%) didn't even perceive a need for treatment, which highlights how misinformation, stigma, and systemic barriers continue to shape access to care. Access to MAT is also far from equitable. CDC data shows that white adults are more likely to receive these medications than Black or Hispanic adults, and men are more likely to access them than women. Adults aged 35-49 had higher rates of medication use than their younger or older peers. The disparities go deeper: People with lower incomes, those who are unemployed, and individuals involved in the criminal legal system had the highest need for OUD treatment. At the same time, they were among the least likely to receive medication-based care, according to the CDC. These gaps underscore the urgent need for more equitable, accessible MAT programs. To better understand the treatment gap, Charlie Health examined the latest research on medications for opioid use disorder (MOUD), including how they work, who they reach, and who's still being left behind. CDC data shows that in 2022, nearly one-third of people with OUD (30%) received treatment without medication—an approach used more often than MAT, even though it's less effective at lowering the risk of overdose. Encouragingly, individuals with severe OUD were significantly more likely to receive medication-based treatment than those with mild or moderate cases, according to a 2021 national study. Concerns about medication safety sometimes prevent people or providers from pursuing MAT. But data consistently shows that MAT is safe, even for people with co-occurring physical health issues. A 2024 study found no increase in ER visits or hospitalizations among people with congestive heart failure who received MAT, supporting its safety across populations with different conditions. Expanding access to MAT in rural areas can be life-changing for those with OUD, especially since people struggling with opioid addiction in rural areas face disproportionate barriers to care. A 2022 study of a Colorado pilot program—which trained 15 new providers and delivered care to more than 1,000 patients—found that, after six months, participants reported reduced opioid, heroin, and alcohol use, along with better physical and mental health. Symptoms of depression, anxiety, and pain all decreased. Programs that make MAT more accessible don't just improve health outcomes; they also reduce healthcare costs. In Vermont, Medicaid beneficiaries enrolled in the state's "Hub & Spoke" program (which expanded access to MAT) had lower ER use and fewer hospitalizations than those who received treatment without medication, research shows. These findings support policy approaches that invest in MAT for OUD not just as a clinical best practice but as a cost-saving public health strategy. The national study conducted in 2021 found that people who accessed care via telehealth were 38 times more likely to receive MAT for OUD than those who didn't. This suggests that virtual care can play a critical role in overcoming geographic or logistical barriers, especially for people in rural or underserved areas. This story was produced by Charlie Health and reviewed and distributed by Stacker.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store